3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Multiple Myeloma
6
Melanoma
5
Glioblastoma
5
Lymphoma
4
Breast Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioma
3
Carcinoma, Ovarian Epithelial
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Neuroblastoma
2
Neoplasms
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Brain Neoplasms
2
Advanced Malignant Solid Tumor
2
Xanthomatosis, Cerebrotendinous
1
Wilms Tumor
1
Vaccinia
1
Interventions
Temozolomide
38
Radiotherapy
22
Radiosurgery
22
Radiation
11
Magnetic Resonance Spectroscopy
11
Irinotecan
11
Cyclophosphamide
11
Etoposide
10
Surgical Procedures, Operative
9
Erlotinib Hydrochloride
9
Carmustine
9
pembrolizumab
8
Filgrastim
8
Carboplatin
8
Bevacizumab
7
Vincristine
6
Sorafenib
6
O(6)-benzylguanine
6
Nivolumab
6
Flucytosine
6
Aminolevulinic Acid
6
temsirolimus
5
sargramostim
5
Vorinostat
5
Trastuzumab
5
Topotecan
5
Lomustine
5
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
Everolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Brain Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled